ST. LOUIS, Nov. 10, 2015 /PRNewswire/ -- Sigma-Aldrich
Corporation (NASDAQ: SIAL) today announced it has secured
final approval from the European Commission (EC) on the planned
acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany.
The EC provided conditional approval of the acquisition on
June 15, 2015, subject to approval of
the divestment of certain Sigma-Aldrich assets. On
October 20, 2015, Sigma-Aldrich
announced an agreement to sell parts of its solvents and inorganics
business to Honeywell. The EC has now approved Honeywell as a
suitable buyer of the divestment business meaning all closing
requirements have been met and the formal completion of the
Sigma-Aldrich acquisition will take place on November 18.
On September 22, 2014, Merck and
Sigma-Aldrich announced they had entered into a definitive
agreement under which Merck will acquire Sigma-Aldrich for
$17 billion - $140 cash per share -
establishing one of the leading players in the $130 billion global life science industry.
About Sigma-Aldrich: Sigma-Aldrich, a leading Life
Science and Technology company focused on enhancing human health
and safety, manufactures and distributes 250,000 chemicals,
biochemicals and other essential products to more than 1.4 million
customers globally in research and applied labs as well as in
industrial and commercial markets. With three distinct
business units - Research, Applied and SAFC Commercial -
Sigma-Aldrich is committed to enabling science to improve the
quality of life. The Company operates in 37 countries, has
approximately 9,700 employees worldwide and had sales of
$2.79 billion in 2014. For more
information about Sigma-Aldrich, please visit its website at
www.sigma-aldrich.com.
Sigma-Aldrich is a registered
trademark of Sigma-Aldrich Co. LLC.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sigma-aldrich-and-merck-kgaa-darmstadt-germany-obtain-ec-antitrust-approval-and-work-toward-closing-planned-acquisition-300175897.html
SOURCE Sigma-Aldrich